HEADER TRANSFERASE 24-NOV-10 3PPL TITLE CRYSTAL STRUCTURE OF AN ASPARTATE TRANSAMINASE (NCGL0237, CGL0240) TITLE 2 FROM CORYNEBACTERIUM GLUTAMICUM ATCC 13032 KITASATO AT 1.25 A TITLE 3 RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: ASPARTATE AMINOTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.6.1.1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CORYNEBACTERIUM GLUTAMICUM; SOURCE 3 ORGANISM_COMMON: BREVIBACTERIUM FLAVUM; SOURCE 4 ORGANISM_TAXID: 196627; SOURCE 5 STRAIN: ATCC 13032 KITASATO; SOURCE 6 GENE: ASPB, CG0294; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS AMINOTRANSFERASE, DIMER, PLP-DEPENDENT TRANSFERASE-LIKE FOLD, KEYWDS 2 STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, KEYWDS 3 PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 4 01-FEB-23 3PPL 1 REMARK SEQADV LINK REVDAT 3 25-OCT-17 3PPL 1 REMARK REVDAT 2 20-JUL-11 3PPL 1 KEYWDS REVDAT 1 22-DEC-10 3PPL 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF AN ASPARTATE TRANSAMINASE (NCGL0237, JRNL TITL 2 CGL0240) FROM CORYNEBACTERIUM GLUTAMICUM ATCC 13032 KITASATO JRNL TITL 3 AT 1.25 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0110 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.32 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 241986 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.106 REMARK 3 R VALUE (WORKING SET) : 0.105 REMARK 3 FREE R VALUE : 0.124 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 12140 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.28 REMARK 3 REFLECTION IN BIN (WORKING SET) : 15868 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.94 REMARK 3 BIN R VALUE (WORKING SET) : 0.1590 REMARK 3 BIN FREE R VALUE SET COUNT : 838 REMARK 3 BIN FREE R VALUE : 0.1840 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6483 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 1228 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.29 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.17000 REMARK 3 B22 (A**2) : 0.20000 REMARK 3 B33 (A**2) : -0.31000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.16000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.031 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.017 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.860 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.985 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.981 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7404 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 4975 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10198 ; 1.598 ; 1.961 REMARK 3 BOND ANGLES OTHERS (DEGREES): 12206 ; 0.966 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1018 ; 5.991 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 341 ;34.581 ;24.370 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1208 ;11.128 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 48 ;12.842 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1103 ; 0.101 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8713 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1545 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4632 ; 1.478 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1861 ; 0.715 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 7557 ; 2.178 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2772 ; 3.231 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2600 ; 4.789 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 12379 ; 1.382 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 1303 ; 8.924 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 12135 ; 4.085 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 3. A PYRIDOXAL-5'-PHOSPHATE (PLP) MOLECULE IS REMARK 3 MODELED IN THE ACTIVE SITE OF EACH MONOMER. 4. AN UNKNOWN LIGAND REMARK 3 (UNL) HAS BEEN MODELED NEAR PLP. 5. THE OCCUPANCIES OF ATOMS IN REMARK 3 ALTERNATE CONFORMATIONS WERE REFINED BY PHENIX SOFTWARE. 3. REMARK 3 GLYCEROL (GOL) MOLECULES FROM THE CRYOPROTECTION SOLUTION ARE REMARK 3 MODELED. REMARK 4 REMARK 4 3PPL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-DEC-10. REMARK 100 THE DEPOSITION ID IS D_1000062663. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-FEB-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837,0.97944,0.97908 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 241991 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.250 REMARK 200 RESOLUTION RANGE LOW (A) : 29.324 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.1 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.03500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.27600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.750 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M SODIUM CHLORIDE, 20.0% REMARK 280 POLYETHYLENE GLYCOL 8000, 0.1M PHOSPHATE-CITRATE PH 4.2, REMARK 280 ADDITIVE: 0.001 M ALPHA-KETOGLUTARIC ACID, NANODROP', VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 48.87750 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.21200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 48.87750 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.21200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: ANALYTICAL SIZE EXCLUSION CHROMATOGRAPHY WITH STATIC LIGHT REMARK 300 SCATTERING SUPPORTS THE ASSIGNMENT OF A DIMER AS A SIGNIFICANT REMARK 300 OLIGOMERIZATION STATE IN SOLUTION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 ASN A 426 REMARK 465 GLY B 0 REMARK 465 MSE B 1 REMARK 465 SER B 2 REMARK 465 SER B 3 REMARK 465 ASN B 426 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 34 CD CE NZ REMARK 470 LYS A 59 CE NZ REMARK 470 GLU A 131 CD OE1 OE2 REMARK 470 GLU A 199 CD OE1 OE2 REMARK 470 GLU A 231 CD OE1 OE2 REMARK 470 GLU A 234 CG CD OE1 OE2 REMARK 470 LYS A 278 CE NZ REMARK 470 LYS B 34 CD CE NZ REMARK 470 LYS B 129 CE NZ REMARK 470 GLU B 131 CD OE1 OE2 REMARK 470 GLU B 209 CD OE1 OE2 REMARK 470 GLU B 234 CG CD OE1 OE2 REMARK 470 LYS B 278 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 SER B 256 CB SER B 256 OG -0.100 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 13 NE - CZ - NH2 ANGL. DEV. = 3.8 DEGREES REMARK 500 ASP A 48 CB - CG - OD1 ANGL. DEV. = 10.3 DEGREES REMARK 500 ASP A 48 CB - CG - OD2 ANGL. DEV. = -11.1 DEGREES REMARK 500 ASP B 10 CB - CG - OD1 ANGL. DEV. = 5.6 DEGREES REMARK 500 ARG B 23 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 62 17.79 -142.88 REMARK 500 ASP A 101 -151.26 -89.56 REMARK 500 HIS A 226 59.50 -100.64 REMARK 500 THR A 261 -86.61 -108.09 REMARK 500 THR A 261 -91.38 -108.09 REMARK 500 PHE B 62 18.84 -140.11 REMARK 500 ASP B 101 -149.92 -88.87 REMARK 500 HIS B 226 58.97 -99.68 REMARK 500 THR B 261 -82.15 -114.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLP A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLP B 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 390716 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3PPL A 1 426 UNP Q6M8B5 Q6M8B5_CORGL 1 426 DBREF 3PPL B 1 426 UNP Q6M8B5 Q6M8B5_CORGL 1 426 SEQADV 3PPL GLY A 0 UNP Q6M8B5 EXPRESSION TAG SEQADV 3PPL GLY B 0 UNP Q6M8B5 EXPRESSION TAG SEQRES 1 A 427 GLY MSE SER SER VAL SER LEU GLN ASP PHE ASP ALA GLU SEQRES 2 A 427 ARG ILE GLY LEU PHE HIS GLU ASP ILE LYS ARG LYS PHE SEQRES 3 A 427 ASP GLU LEU LYS SER LYS ASN LEU LYS LEU ASP LEU THR SEQRES 4 A 427 ARG GLY LYS PRO SER SER GLU GLN LEU ASP PHE ALA ASP SEQRES 5 A 427 GLU LEU LEU ALA LEU PRO GLY LYS GLY ASP PHE LYS ALA SEQRES 6 A 427 ALA ASP GLY THR ASP VAL ARG ASN TYR GLY GLY LEU ASP SEQRES 7 A 427 GLY ILE VAL ASP ILE ARG GLN ILE TRP ALA ASP LEU LEU SEQRES 8 A 427 GLY VAL PRO VAL GLU GLN VAL LEU ALA GLY ASP ALA SER SEQRES 9 A 427 SER LEU ASN ILE MSE PHE ASP VAL ILE SER TRP SER TYR SEQRES 10 A 427 ILE PHE GLY ASN ASN ASP SER VAL GLN PRO TRP SER LYS SEQRES 11 A 427 GLU GLU THR VAL LYS TRP ILE CYS PRO VAL PRO GLY TYR SEQRES 12 A 427 ASP ARG HIS PHE SER ILE THR GLU ARG PHE GLY PHE GLU SEQRES 13 A 427 MSE ILE SER VAL PRO MSE ASN GLU ASP GLY PRO ASP MSE SEQRES 14 A 427 ASP ALA VAL GLU GLU LEU VAL LYS ASN PRO GLN VAL LYS SEQRES 15 A 427 GLY MSE TRP VAL VAL PRO VAL PHE SER ASN PRO THR GLY SEQRES 16 A 427 PHE THR VAL THR GLU ASP VAL ALA LYS ARG LEU SER ALA SEQRES 17 A 427 MSE GLU THR ALA ALA PRO ASP PHE ARG VAL VAL TRP ASP SEQRES 18 A 427 ASN ALA TYR ALA VAL HIS THR LEU THR ASP GLU PHE PRO SEQRES 19 A 427 GLU VAL ILE ASP ILE VAL GLY LEU GLY GLU ALA ALA GLY SEQRES 20 A 427 ASN PRO ASN ARG PHE TRP ALA PHE THR SER THR SER LYS SEQRES 21 A 427 ILE THR LEU ALA GLY ALA GLY VAL SER PHE PHE LEU THR SEQRES 22 A 427 SER ALA GLU ASN ARG LYS TRP TYR THR GLY HIS ALA GLY SEQRES 23 A 427 ILE ARG GLY ILE GLY PRO ASN LYS VAL ASN GLN LEU ALA SEQRES 24 A 427 HIS ALA ARG TYR PHE GLY ASP ALA GLU GLY VAL ARG ALA SEQRES 25 A 427 VAL MSE ARG LYS HIS ALA ALA SER LEU ALA PRO LYS PHE SEQRES 26 A 427 ASN LYS VAL LEU GLU ILE LEU ASP SER ARG LEU ALA GLU SEQRES 27 A 427 TYR GLY VAL ALA GLN TRP THR VAL PRO ALA GLY GLY TYR SEQRES 28 A 427 PHE ILE SER LEU ASP VAL VAL PRO GLY THR ALA SER ARG SEQRES 29 A 427 VAL ALA GLU LEU ALA LYS GLU ALA GLY ILE ALA LEU THR SEQRES 30 A 427 GLY ALA GLY SER SER TYR PRO LEU ARG GLN ASP PRO GLU SEQRES 31 A 427 ASN LYS ASN LEU ARG LEU ALA PRO SER LEU PRO PRO VAL SEQRES 32 A 427 GLU GLU LEU GLU VAL ALA MSE ASP GLY VAL ALA THR CYS SEQRES 33 A 427 VAL LEU LEU ALA ALA ALA GLU HIS TYR ALA ASN SEQRES 1 B 427 GLY MSE SER SER VAL SER LEU GLN ASP PHE ASP ALA GLU SEQRES 2 B 427 ARG ILE GLY LEU PHE HIS GLU ASP ILE LYS ARG LYS PHE SEQRES 3 B 427 ASP GLU LEU LYS SER LYS ASN LEU LYS LEU ASP LEU THR SEQRES 4 B 427 ARG GLY LYS PRO SER SER GLU GLN LEU ASP PHE ALA ASP SEQRES 5 B 427 GLU LEU LEU ALA LEU PRO GLY LYS GLY ASP PHE LYS ALA SEQRES 6 B 427 ALA ASP GLY THR ASP VAL ARG ASN TYR GLY GLY LEU ASP SEQRES 7 B 427 GLY ILE VAL ASP ILE ARG GLN ILE TRP ALA ASP LEU LEU SEQRES 8 B 427 GLY VAL PRO VAL GLU GLN VAL LEU ALA GLY ASP ALA SER SEQRES 9 B 427 SER LEU ASN ILE MSE PHE ASP VAL ILE SER TRP SER TYR SEQRES 10 B 427 ILE PHE GLY ASN ASN ASP SER VAL GLN PRO TRP SER LYS SEQRES 11 B 427 GLU GLU THR VAL LYS TRP ILE CYS PRO VAL PRO GLY TYR SEQRES 12 B 427 ASP ARG HIS PHE SER ILE THR GLU ARG PHE GLY PHE GLU SEQRES 13 B 427 MSE ILE SER VAL PRO MSE ASN GLU ASP GLY PRO ASP MSE SEQRES 14 B 427 ASP ALA VAL GLU GLU LEU VAL LYS ASN PRO GLN VAL LYS SEQRES 15 B 427 GLY MSE TRP VAL VAL PRO VAL PHE SER ASN PRO THR GLY SEQRES 16 B 427 PHE THR VAL THR GLU ASP VAL ALA LYS ARG LEU SER ALA SEQRES 17 B 427 MSE GLU THR ALA ALA PRO ASP PHE ARG VAL VAL TRP ASP SEQRES 18 B 427 ASN ALA TYR ALA VAL HIS THR LEU THR ASP GLU PHE PRO SEQRES 19 B 427 GLU VAL ILE ASP ILE VAL GLY LEU GLY GLU ALA ALA GLY SEQRES 20 B 427 ASN PRO ASN ARG PHE TRP ALA PHE THR SER THR SER LYS SEQRES 21 B 427 ILE THR LEU ALA GLY ALA GLY VAL SER PHE PHE LEU THR SEQRES 22 B 427 SER ALA GLU ASN ARG LYS TRP TYR THR GLY HIS ALA GLY SEQRES 23 B 427 ILE ARG GLY ILE GLY PRO ASN LYS VAL ASN GLN LEU ALA SEQRES 24 B 427 HIS ALA ARG TYR PHE GLY ASP ALA GLU GLY VAL ARG ALA SEQRES 25 B 427 VAL MSE ARG LYS HIS ALA ALA SER LEU ALA PRO LYS PHE SEQRES 26 B 427 ASN LYS VAL LEU GLU ILE LEU ASP SER ARG LEU ALA GLU SEQRES 27 B 427 TYR GLY VAL ALA GLN TRP THR VAL PRO ALA GLY GLY TYR SEQRES 28 B 427 PHE ILE SER LEU ASP VAL VAL PRO GLY THR ALA SER ARG SEQRES 29 B 427 VAL ALA GLU LEU ALA LYS GLU ALA GLY ILE ALA LEU THR SEQRES 30 B 427 GLY ALA GLY SER SER TYR PRO LEU ARG GLN ASP PRO GLU SEQRES 31 B 427 ASN LYS ASN LEU ARG LEU ALA PRO SER LEU PRO PRO VAL SEQRES 32 B 427 GLU GLU LEU GLU VAL ALA MSE ASP GLY VAL ALA THR CYS SEQRES 33 B 427 VAL LEU LEU ALA ALA ALA GLU HIS TYR ALA ASN MODRES 3PPL MSE A 108 MET SELENOMETHIONINE MODRES 3PPL MSE A 156 MET SELENOMETHIONINE MODRES 3PPL MSE A 161 MET SELENOMETHIONINE MODRES 3PPL MSE A 168 MET SELENOMETHIONINE MODRES 3PPL MSE A 183 MET SELENOMETHIONINE MODRES 3PPL MSE A 208 MET SELENOMETHIONINE MODRES 3PPL MSE A 313 MET SELENOMETHIONINE MODRES 3PPL MSE A 409 MET SELENOMETHIONINE MODRES 3PPL MSE B 108 MET SELENOMETHIONINE MODRES 3PPL MSE B 156 MET SELENOMETHIONINE MODRES 3PPL MSE B 161 MET SELENOMETHIONINE MODRES 3PPL MSE B 168 MET SELENOMETHIONINE MODRES 3PPL MSE B 183 MET SELENOMETHIONINE MODRES 3PPL MSE B 208 MET SELENOMETHIONINE MODRES 3PPL MSE B 313 MET SELENOMETHIONINE MODRES 3PPL MSE B 409 MET SELENOMETHIONINE HET MSE A 108 8 HET MSE A 156 8 HET MSE A 161 8 HET MSE A 168 8 HET MSE A 183 16 HET MSE A 208 8 HET MSE A 313 8 HET MSE A 409 13 HET MSE B 108 8 HET MSE B 156 8 HET MSE B 161 8 HET MSE B 168 8 HET MSE B 183 16 HET MSE B 208 8 HET MSE B 313 8 HET MSE B 409 13 HET PLP A 500 16 HET UNL A 600 12 HET PLP B 500 16 HET UNL B 600 10 HET GOL B 700 6 HET GOL B 701 6 HETNAM MSE SELENOMETHIONINE HETNAM PLP PYRIDOXAL-5'-PHOSPHATE HETNAM UNL UNKNOWN LIGAND HETNAM GOL GLYCEROL HETSYN PLP VITAMIN B6 PHOSPHATE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 MSE 16(C5 H11 N O2 SE) FORMUL 3 PLP 2(C8 H10 N O6 P) FORMUL 7 GOL 2(C3 H8 O3) FORMUL 9 HOH *1228(H2 O) HELIX 1 1 SER A 5 PHE A 9 5 5 HELIX 2 2 ASP A 10 LYS A 31 1 22 HELIX 3 3 SER A 43 PHE A 49 1 7 HELIX 4 4 ALA A 50 LEU A 56 5 7 HELIX 5 5 ILE A 79 GLY A 91 1 13 HELIX 6 6 PRO A 93 GLU A 95 5 3 HELIX 7 7 SER A 103 GLY A 119 1 17 HELIX 8 8 PRO A 126 GLU A 130 5 5 HELIX 9 9 TYR A 142 PHE A 152 1 11 HELIX 10 10 ASP A 167 VAL A 175 1 9 HELIX 11 11 THR A 198 MSE A 208 1 11 HELIX 12 12 ASP A 237 ALA A 245 1 9 HELIX 13 13 SER A 273 GLY A 288 1 16 HELIX 14 14 ASN A 292 GLY A 304 1 13 HELIX 15 15 ASP A 305 ALA A 336 1 32 HELIX 16 16 GLU A 337 GLY A 339 5 3 HELIX 17 17 THR A 360 ALA A 371 1 12 HELIX 18 18 TYR A 382 GLN A 386 5 5 HELIX 19 19 PRO A 401 ALA A 425 1 25 HELIX 20 20 SER B 5 PHE B 9 5 5 HELIX 21 21 ASP B 10 LYS B 31 1 22 HELIX 22 22 SER B 43 PHE B 49 1 7 HELIX 23 23 ALA B 50 LEU B 56 5 7 HELIX 24 24 ILE B 79 GLY B 91 1 13 HELIX 25 25 PRO B 93 GLU B 95 5 3 HELIX 26 26 SER B 103 GLY B 119 1 17 HELIX 27 27 PRO B 126 GLU B 130 5 5 HELIX 28 28 TYR B 142 PHE B 152 1 11 HELIX 29 29 ASP B 167 VAL B 175 1 9 HELIX 30 30 THR B 198 MSE B 208 1 11 HELIX 31 31 ASP B 237 ALA B 245 1 9 HELIX 32 32 SER B 273 GLY B 288 1 16 HELIX 33 33 ASN B 292 GLY B 304 1 13 HELIX 34 34 ASP B 305 ALA B 336 1 32 HELIX 35 35 GLU B 337 GLY B 339 5 3 HELIX 36 36 THR B 360 ALA B 371 1 12 HELIX 37 37 TYR B 382 GLN B 386 5 5 HELIX 38 38 PRO B 401 ALA B 425 1 25 SHEET 1 A 2 LEU A 35 ASP A 36 0 SHEET 2 A 2 ILE A 373 ALA A 374 1 O ALA A 374 N LEU A 35 SHEET 1 B 8 VAL A 97 ALA A 99 0 SHEET 2 B 8 SER A 268 LEU A 271 -1 O PHE A 270 N LEU A 98 SHEET 3 B 8 PHE A 251 SER A 256 -1 N ALA A 253 O LEU A 271 SHEET 4 B 8 ARG A 216 ASP A 220 1 N VAL A 217 O TRP A 252 SHEET 5 B 8 VAL A 180 VAL A 185 1 N VAL A 185 O ASP A 220 SHEET 6 B 8 LYS A 134 VAL A 139 1 N ILE A 136 O GLY A 182 SHEET 7 B 8 GLU A 155 ASN A 162 1 O ILE A 157 N CYS A 137 SHEET 8 B 8 GLY A 165 PRO A 166 -1 O GLY A 165 N ASN A 162 SHEET 1 C 3 GLN A 342 TRP A 343 0 SHEET 2 C 3 ILE A 352 ASP A 355 -1 O ASP A 355 N GLN A 342 SHEET 3 C 3 ASN A 392 LEU A 395 -1 O LEU A 393 N LEU A 354 SHEET 1 D 2 LEU B 35 ASP B 36 0 SHEET 2 D 2 ILE B 373 ALA B 374 1 O ALA B 374 N LEU B 35 SHEET 1 E 8 VAL B 97 ALA B 99 0 SHEET 2 E 8 SER B 268 LEU B 271 -1 O PHE B 270 N LEU B 98 SHEET 3 E 8 PHE B 251 SER B 256 -1 N ALA B 253 O LEU B 271 SHEET 4 E 8 ARG B 216 ASP B 220 1 N VAL B 217 O TRP B 252 SHEET 5 E 8 VAL B 180 VAL B 185 1 N VAL B 185 O ASP B 220 SHEET 6 E 8 LYS B 134 VAL B 139 1 N ILE B 136 O GLY B 182 SHEET 7 E 8 GLU B 155 ASN B 162 1 O ILE B 157 N CYS B 137 SHEET 8 E 8 GLY B 165 PRO B 166 -1 O GLY B 165 N ASN B 162 SHEET 1 F 3 GLN B 342 TRP B 343 0 SHEET 2 F 3 ILE B 352 ASP B 355 -1 O ASP B 355 N GLN B 342 SHEET 3 F 3 ASN B 392 LEU B 395 -1 O LEU B 393 N LEU B 354 LINK C ILE A 107 N MSE A 108 1555 1555 1.34 LINK C MSE A 108 N PHE A 109 1555 1555 1.33 LINK C AGLU A 155 N MSE A 156 1555 1555 1.33 LINK C BGLU A 155 N MSE A 156 1555 1555 1.33 LINK C MSE A 156 N ILE A 157 1555 1555 1.31 LINK C PRO A 160 N MSE A 161 1555 1555 1.34 LINK C MSE A 161 N ASN A 162 1555 1555 1.33 LINK C AASP A 167 N MSE A 168 1555 1555 1.33 LINK C BASP A 167 N MSE A 168 1555 1555 1.33 LINK C MSE A 168 N ASP A 169 1555 1555 1.33 LINK C GLY A 182 N AMSE A 183 1555 1555 1.32 LINK C GLY A 182 N BMSE A 183 1555 1555 1.34 LINK C AMSE A 183 N TRP A 184 1555 1555 1.33 LINK C BMSE A 183 N TRP A 184 1555 1555 1.34 LINK C ALA A 207 N MSE A 208 1555 1555 1.33 LINK C MSE A 208 N AGLU A 209 1555 1555 1.32 LINK C MSE A 208 N BGLU A 209 1555 1555 1.34 LINK C VAL A 312 N MSE A 313 1555 1555 1.33 LINK C MSE A 313 N ARG A 314 1555 1555 1.34 LINK C ALA A 408 N MSE A 409 1555 1555 1.33 LINK C MSE A 409 N ASP A 410 1555 1555 1.32 LINK C ILE B 107 N MSE B 108 1555 1555 1.33 LINK C MSE B 108 N PHE B 109 1555 1555 1.33 LINK C AGLU B 155 N MSE B 156 1555 1555 1.32 LINK C BGLU B 155 N MSE B 156 1555 1555 1.33 LINK C MSE B 156 N ILE B 157 1555 1555 1.32 LINK C PRO B 160 N MSE B 161 1555 1555 1.33 LINK C MSE B 161 N ASN B 162 1555 1555 1.34 LINK C ASP B 167 N MSE B 168 1555 1555 1.33 LINK C MSE B 168 N ASP B 169 1555 1555 1.32 LINK C GLY B 182 N AMSE B 183 1555 1555 1.32 LINK C GLY B 182 N BMSE B 183 1555 1555 1.33 LINK C AMSE B 183 N TRP B 184 1555 1555 1.32 LINK C BMSE B 183 N TRP B 184 1555 1555 1.33 LINK C ALA B 207 N MSE B 208 1555 1555 1.34 LINK C MSE B 208 N GLU B 209 1555 1555 1.32 LINK C VAL B 312 N MSE B 313 1555 1555 1.33 LINK C MSE B 313 N AARG B 314 1555 1555 1.33 LINK C MSE B 313 N BARG B 314 1555 1555 1.32 LINK C ALA B 408 N MSE B 409 1555 1555 1.33 LINK C MSE B 409 N ASP B 410 1555 1555 1.32 CISPEP 1 LEU A 56 PRO A 57 0 5.67 CISPEP 2 VAL A 139 PRO A 140 0 -10.89 CISPEP 3 ASN A 191 PRO A 192 0 8.91 CISPEP 4 LEU B 56 PRO B 57 0 4.93 CISPEP 5 VAL B 139 PRO B 140 0 -6.92 CISPEP 6 ASN B 191 PRO B 192 0 12.27 SITE 1 AC1 16 SER A 103 SER A 104 LEU A 105 TYR A 142 SITE 2 AC1 16 VAL A 186 ASN A 191 ASP A 220 ALA A 222 SITE 3 AC1 16 TYR A 223 SER A 256 SER A 258 LYS A 259 SITE 4 AC1 16 HOH A 723 HOH A 735 HOH A 891 TYR B 73 SITE 1 AC2 16 TYR A 73 SER B 103 SER B 104 LEU B 105 SITE 2 AC2 16 TYR B 142 VAL B 186 ASN B 191 ASP B 220 SITE 3 AC2 16 ALA B 222 TYR B 223 SER B 256 SER B 258 SITE 4 AC2 16 LYS B 259 HOH B 715 HOH B 745 HOH B 892 SITE 1 AC3 9 ASP B 20 ALA B 321 PHE B 324 LEU B 328 SITE 2 AC3 9 VAL B 345 PRO B 346 HOH B 776 HOH B1032 SITE 3 AC3 9 HOH B1862 SITE 1 AC4 4 GLN B 342 TRP B 343 HOH B1316 HOH B1336 CRYST1 97.755 54.424 176.340 90.00 101.60 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010230 0.000000 0.002100 0.00000 SCALE2 0.000000 0.018374 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005789 0.00000